MorphoSys accelerates own-product development

With US regulatory approval of a partnered antibody product now in hand, MorphoSys AG has started to move quickly to consolidate its position as an independent drug developer.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany